Clinical Trial Update: Safety, Efficacy and Pharmacokinetics of NNC-0156-0000-0009 in Previously Treated Children With Haemophilia B. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety, efficacy and pharmacokinetics of NNC-0156-0000-0009 in previously treated children with Haemophilia B has completed and p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia

Drugs mentioned

• NNC-0156-0000-0009

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia B | Phase 3 | Status: COMPLETED | Results posted: 2017-11-17